K65R with and without S68: a new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.


Antiretroviral treatment with three nucleoside reverse transcriptase inhibitors (NRTIs) is widely used, but the combination of abacavir, didanosine and stavudine has never been investigated. We describe the surprising and consistent genotypic and phenotypic outcome in patients failing this combination. As part of a Danish multicentre study, 60… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.